How should I manage periorbital eczema in a woman presenting with patches around the eyes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Periorbital Eczema

Tacrolimus 0.1% ointment applied once daily to the external eyelids and lid margins for 2-4 weeks is the first-line treatment for adults with periorbital eczema. 1

First-Line Therapy: Topical Calcineurin Inhibitors

Topical calcineurin inhibitors are the preferred initial treatment because they avoid the risks of corticosteroid-induced skin atrophy, which is particularly problematic in the thin periorbital skin. 2, 1, 3

Treatment protocol:

  • Adults: Tacrolimus 0.1% ointment applied once daily to external eyelids including lid margins for 2-4 weeks 2, 1
  • Children (ages 2-17): Tacrolimus 0.03% ointment applied once daily for 2-4 weeks, ideally following ophthalmology consultation 2, 1
  • For maximum effect: Calcineurin inhibitors may be applied directly to the lid margins (ocular surface) when initiated by an ophthalmologist 2, 1

Critical Safety Contraindications

Absolute contraindications to tacrolimus:

  • Never use tacrolimus in patients with a history of ocular-surface herpes simplex virus or varicella zoster virus infection 2, 1, 4
  • Intralesional steroids are absolutely prohibited in the periorbital region due to severe risks including central retinal artery embolism, tissue necrosis, fat atrophy, and full-thickness eyelid necrosis 1, 4

Mandatory ophthalmology referral:

  • Arrange ophthalmology review within 4 weeks when initiating any periocular treatment, especially in children or when applying medications to lid margins 2, 1

Essential Adjunctive Skin-Care Measures (All Patients)

These measures address the underlying barrier dysfunction in eczema and are critical for treatment success:

  • Replace all soaps and detergents with a dispersible cream-type cleanser to preserve the skin's natural lipid barrier 1
  • Apply liberal amounts of emollient immediately after bathing to create a surface lipid film that limits evaporative water loss 1
  • Keep fingernails trimmed short to reduce trauma from scratching 1
  • Avoid irritant fabrics (especially wool) near the face; use cotton-based clothing instead 1
  • Eliminate all irritants including soaps, detergents, and excessive water exposure 4

When Topical Corticosteroids Are Needed

Use corticosteroids only after calcineurin inhibitor failure or when contraindicated:

  • Select the lowest-potency corticosteroid that achieves disease control 1
  • Limit application to no more than twice daily (newer formulations may be used once daily) 1
  • Very potent or potent corticosteroids should be used only for short periods because of the risk of hypothalamic-pituitary-adrenal axis suppression and growth interference in children 1
  • Interrupt corticosteroid therapy for brief drug-free intervals whenever clinically feasible 1

Management of Secondary Infections

Secondary bacterial or viral infections are common complications that require prompt treatment:

Bacterial infections:

  • Flucloxacillin is the first-choice oral antibiotic for secondary Staphylococcus aureus infection 1
  • Phenoxymethylpenicillin is recommended when β-hemolytic streptococci are isolated 1
  • Erythromycin is indicated for flucloxacillin-resistant infections or in patients with penicillin allergy 1

Viral infections:

  • For eczema herpeticum, initiate oral acyclovir promptly 1
  • Use intravenous acyclovir for severely ill or febrile patients 1

Adjunctive Therapy for Severe Pruritus

  • Short-term sedating antihistamines can be used at night to improve sleep during severe itch flares; their benefit is primarily due to sedation rather than antihistamine effect 1
  • Avoid daytime use of sedating antihistamines to prevent sedation-related impairment 1
  • Non-sedating antihistamines have little or no therapeutic value in atopic eczema 1
  • Higher doses may be required in pediatric patients to achieve adequate sedation 1

Identifying and Managing Contact Allergens

Allergic contact dermatitis is a common cause of periorbital eczema, found in 32-52% of cases. 3, 5, 6 This is particularly important because even patients with atopic dermatitis may have superimposed allergic contact dermatitis (positive patch tests in one-third of atopic patients). 5

Most common allergens causing periorbital eczema:

  • Antibiotics, phenylephrine, and thimerosal are the leading allergens 5
  • Fragrances, preservatives, and drugs in cosmetics 3
  • Leave-on cosmetic products (face cream, eye shadow) and eye drops 3
  • Nickel sulphate (8.9%), fragrance mix I (4.5%), balsam of Peru (4.0%), and paraphenylenediamine (3.7%) 6

When to suspect allergic contact dermatitis:

  • Female gender, atopic skin diathesis, and age 40 years or older are risk factors 3
  • Consider patch testing when patients fail to respond to first-line therapy 5, 6
  • Test patients with their own products (eye ointments, face creams, eye shadows, makeup, shampoos, nail varnish) 5

Referral Recommendations

Refer to a specialist when:

  • The patient does not respond to first-line calcineurin inhibitors combined with appropriate emollient therapy 1
  • Diagnostic uncertainty exists 7
  • Failure to respond to maintenance treatment with mildly potent steroids in children or moderately potent steroids in adults 7

Important: The specialist should first reinforce adherence to first-line measures (calcineurin inhibitors and emollients) before considering second-line options. 1

Common Pitfalls to Avoid

  • Do not withhold treatment because of steroid phobia; using calcineurin inhibitors as first-line therapy eliminates the need for potent steroids in the periorbital area 1
  • Do not overlook allergic contact dermatitis, even in patients with known atopic dermatitis—patch testing may be necessary 5
  • Do not use intralesional steroids in the periorbital area under any circumstances 1, 4
  • Do not apply tacrolimus to patients with a history of ocular herpes simplex or varicella zoster 4

References

Guideline

Management of Periorbital Eczema

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment of Periorbital Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Periorbital dermatitis: causes, differential diagnoses and therapy.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2010

Guideline

Management of Periorbital Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Periocular dermatitis: a report of 401 patients.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.